SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs Q3 earnings report is driving attention, with traders citing a broad beat and strong growth but noting the share prices muted, volatile reaction. The debate centers on whether heavy AI-related capital spending and the companys valuation outweigh the results, with some also watching for potential selling as shares become available.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly results beat earnings expectations with revenue roughly in line, but softer forward guidanceparticularly for the next quarter and advertisinghas driven a selloff. Traders are split between focusing on slower growth and a weaker outlook, and viewing the results, stronger margins and buybacks as reasons to buy the dip.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A sharp rebound on heavy volume has renewed speculation that SELLAS is nearing a catalyst, especially the REGAL Phase 3 trials 80th-event trigger for final analysis; some traders also read the CEOs anniversary remarks as a possible buyout signal. Others emphasize that no new trial results or deal have been confirmed and view the move as volatile trading without fresh news.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Q3 results sparked a sharp selloff despite beating expectations, as traders focused on slower da Vinci procedure growth, an unchanged full-year growth outlook, and a one-time antitrust settlement charge. Some see the reaction as an overdone buying opportunity, while others argue that decelerating growth and the stocks premium valuation justify the reset.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros preliminary Q1 update, with revenue and gross-margin outlook above prior guidance on stronger AI-platform demand, drove the sudden burst of attention. Traders cheered the news and speculated about a short squeeze, while skeptics pointed to the stocks steep recent decline, governance concerns and broader worries about AI spending.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

The FAAs certification of Boeings 737 MAX 10 is the main catalyst, clearing a long-standing regulatory hurdle for a model tied to a sizable share of the 737 backlog. Traders are frustrated that the approval has not lifted the stock, arguing it may be priced in and that production, deliveries, and cash generation remain the bigger tests.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

Uniteds Q3 results missed expectations and its Q4 outlook disappointed, with sharply higher fuel costs weighing on profitability. Traders are debating whether resilient travel demand and revenue growth can offset the margin pressure, with some viewing the pullback as overdone and others concerned fuel costs will continue to squeeze earnings.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea shares are selling off after reports that it plans to list fintech arm Monee and launch an AI cloud business, despite some traders viewing the moves as potential growth opportunities. The community is divided over whether the plans could unlock value or create uncertainty and spending concerns, while many point to the stocks sharp technical breakdown.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas Q3 earnings report is the main focus, with traders weighing the recent rebound against concerns about margins, valuation and whether updates on robotaxis or Optimus can support the companys growth story. Some expect a strong report, while others warn of a sell-the-news reaction; unconfirmed SpaceX merger speculation is also adding to the debate.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GEs earnings beat and raised outlook were met with a sharp selloff, prompting traders to question why strong demand has not translated into gains. The community attributes the reaction to selling after the report and concerns about rising costs, weaker cash conversion, and an insurance loss, while bulls argue the underlying demand and outlook remain strong.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders?

Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders? Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 21, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--NCSM, PSBQ, LAB, and RLYB

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--NCSM, PSBQ, LAB, and RLYB $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--NCSM, PSBQ, LAB, and RLYB PR Newswire NEW YORK, July 20, 2026 NEW YORK, July 20, 2026 /PRNewswire...

Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?

Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders? Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 9, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

RLYB Stock Alert: Halper Sadeh LLC is Investigating Whether Rallybio Corporation is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Rallybio Corporation (NASDAQ: RLYB) and Avenzo Therapeutics, Inc. Upon closing of the proposed transaction, Rallybio shareholders are expected to own approximately 2.8% of the combined company.Halper Sadeh encourages...

RLYB Stock Hits 2-Year Highs After Unveiling Merger With Avenzo – How Much Of The New Company Will Rallybio Shareholders Own?

Equity

Rallybio announced a merger agreement with Avenzo Therapeutics to create a publicly traded, oncology-focused biotechnology company.

Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement

Rallybio Corporation (Nasdaq: RLYB) ("Rallybio") and Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced that they have entered into a definitive agreement pursuant to which Rallybio will acquire Avenzo through...

Rallybio (RLYB) Projected to Post Quarterly Earnings on Tuesday

Rallybio (NASDAQ:RLYB) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at...

Best Biotech Stocks To Research - May 4th

Celcuity, Danaher, Vertex Pharmaceuticals, Rallybio, and Moderna are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies focused on developing biological products, drugs, diagnostics, or platform technologies...

Institutional Giants Are Piling into Four of These NASDAQ Plays

The market is currently seeing a flurry of activity as companies across the biotech and technology sectors secure substantial funding and execute strategic transformations. $CNSP, $KBLB, $PN, $RLYB, $ADVB, $CLNN, $CABA

Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders?

Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 9, 2026 Insiders may stand to...

Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is headquartered in New Haven, CT.

Rallybio Corp

Bearish Sentiment

<ul class="summary-bullets"><li>The combined company will operate under the name Avenzo Therapeutics and is expected to trade on Nasdaq under the ticker symbol AVZO.</li><li>Avenzo secured $215 million in private placement financing from Vivo Capital, Lilly Asia Ventures, and Blackstone Multi-Asset Investing, among others.</li><li>Last month, Candid Therapeutics terminated a merger deal with RallyBio to pursue an agreement with UCB.</li></ul>Shares of Rallybio Corp. (RLYB) surged more than 20% on Monday, reaching their highest level in over two years, after the biotech firm unveiled a merger with Avenzo Therapeutics, a deal that enhances its portfolio of next-generation cancer treatments and adds a substantial cash runway.This comes less than a month after Candid Therapeutics terminated a merger deal with RallyBio to pursue an agreement with UCB. The two firms had signed an agreement in March 2026.<h2 class="st-heading-2">Combined Firm To Trade Under AVZO Ticker</h2>The combined company will operate under the name Avenzo Therapeutics and is expected to trade on Nasdaq under the ticker symbol AVZO. The transaction is expected to close in the fourth quarter of 2026.Avenzo secured a $215 million in private placement financing from a group of healthcare-focused institutional investors, including Vivo Capital, Lilly Asia Ventures, and Blackstone Multi-Asset Investing, among others.The company said the proceeds are expected to fund operations into late 2028 and support several upcoming clinical milestones.Following the deal, existing Avenzo shareholders are expected to own about 97.2% of the combined company, while Rallybio shareholders will hold roughly 2.8%.<h2 class="st-heading-2">Combining Forces In Oncology</h2>Avenzo brings a portfolio of four clinical-stage oncology programs, including targeted small molecules and antibody-drug conjugates (ADCs) for the treatment of tumors. Its lead candidates include AVZO-021 and AVZO-023 for breast cancer, along with AVZO-1418 and AVZO-103, which are being studied across multiple tumor types.Meanwhile, Rallybio develops treatments for rare and serious diseases. Its pipeline includes therapies targeting conditions with limited treatment options, particularly in blood disorders and diseases linked to immune system dysfunction.<h2 class="st-heading-2">RLYB Sentiment Remains Bearish</h2>Despite the sharp rally, retail sentiment for <a href="https://stocktwits.com/symbol/RLYB">RLYB</a> on Stocktwits trended in the ‘bearish’ territory over the past 24 hours.One user said, despite the share price spike, there are “lots of issues.”<stembedurl>https://stocktwits.com/TA_Kongen/message/654947336</stembedurl>The stock has ripped 230% so far this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/oncy-stock-gains-on-lead-therapy-promise/cZ0gw0DReHv">ONCY Stock Heads For Sixth Straight Session Of Gains – Lead Therapy Shines in Early Combination Treatment Study</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

On Monday, Deutsche Bank said CAR’s downgrade to ‘Hold’ from ‘Buy' is "purely fundamental in nature"

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$16.38
Prev Close	$16.35
Open	$16.48
Dividend Yield	0.00%
50-Day Moving Average	$16.85
Beta	1.31
Avg. Volume	10,731.02
PE Ratio	2.09

52-Week High	$17.57
52-Week Low	$3.67
Market Capitalization	$86.86M
EPS (Annual)	-$1.59
Price to Book	0.92
Revenue Per Employee	$61,285.71

Feed

News

Sentiment

Earnings

Fundamentals

Info

RLYB Fundamentals